- Home
- ICG vs IOBT Comparison
ICG vs IOBT Comparison
Compare ICG & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICG
- IOBT
- Stock Information
- Founded
- ICG 2017
- IOBT 2014
- Country
- ICG China
- IOBT Denmark
- Employees
- ICG N/A
- IOBT N/A
- Industry
- ICG Semiconductors
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- ICG Technology
- IOBT Health Care
- Exchange
- ICG Nasdaq
- IOBT Nasdaq
- Market Cap
- ICG 105.7M
- IOBT 91.6M
- IPO Year
- ICG 2023
- IOBT 2021
- Fundamental
- Price
- ICG $2.80
- IOBT $1.41
- Analyst Decision
- ICG Strong Buy
- IOBT Strong Buy
- Analyst Count
- ICG 2
- IOBT 3
- Target Price
- ICG $9.25
- IOBT $9.33
- AVG Volume (30 Days)
- ICG 346.9K
- IOBT 173.0K
- Earning Date
- ICG 08-14-2025
- IOBT 08-12-2025
- Dividend Yield
- ICG N/A
- IOBT N/A
- EPS Growth
- ICG N/A
- IOBT N/A
- EPS
- ICG 0.07
- IOBT N/A
- Revenue
- ICG $53,729,346.00
- IOBT N/A
- Revenue This Year
- ICG N/A
- IOBT N/A
- Revenue Next Year
- ICG $141.94
- IOBT N/A
- P/E Ratio
- ICG $36.80
- IOBT N/A
- Revenue Growth
- ICG 384.54
- IOBT N/A
- 52 Week Low
- ICG $1.19
- IOBT $0.66
- 52 Week High
- ICG $12.04
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- ICG 66.82
- IOBT 55.98
- Support Level
- ICG $1.75
- IOBT $1.37
- Resistance Level
- ICG $2.79
- IOBT $1.48
- Average True Range (ATR)
- ICG 0.38
- IOBT 0.09
- MACD
- ICG 0.13
- IOBT -0.01
- Stochastic Oscillator
- ICG 89.18
- IOBT 68.33
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.